Topic Archives: rapamycin

Today we’ve got a teaser pitch from Marc Lichtenfeld to consider. It’s an ad for his Oxford Income Letter, but the “fountain of youth” pitch makes it sound like a wild ride of a biotech idea… so let’s dig in and see what we can find, shall we? Sometimes it’s best to start with the […]

Comments

  • Avatar

    The interview at the following site shows what rapamycin did for Dr. Alan S. Green. Whether that means that TORC will d...

  • Avatar

    NT Shudder. It bothers me to take anything, let alone Rapamycin, a pill that may lead to lymphoma. You never really know...

  • Avatar

    Fascinting article on CNN.com about Rapamycin, a drug manufactured by Pfizer: Developed first as an anti-fungal, used t...

  • Avatar

    Travis, I had two organ transplants in 2000 and I started taking Rapamycin as my anti-rejection after prograff gave me ...

  • Dr. KSS MD PhD

    Malis totalis. Rapamycin has been in clinical use for decades for solid organ transplant recipients. It'll cause you can...

  • Michael Jorrin (aka Doc Gumshoe)

    The rapamycin - everolimus story is not all that new. I wrote about it in my aging piece in August. In mice, everoli...

  • Dr. KSS, MD PhD

    John: none at present that I know of. Most forms of polycystic kidney disease are autosomal dominant, and this may make ...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch